Answers are grounded in this paper and cite their sources.
A new process was developed for the synthesis of ( R )-tamsulosin in 4 chemical steps from readily available 4-methoxyphenylacetone using continuous chlorosulfonation and biocatalysis. Several conditions were tested for both batch and continuous chlorosulfonation of 4-methoxyphenylacetone. Continuous chlorosulfonation produced a white crystalline solid, while a brown solid or dark oil was consistently obtained when the reaction was performed in batch. Consequently, the sulfonamide intermediate was isolated as a white product in the continuous process, albeit in a slightly lower yield. Immobilized Escherichia coli whole cells overexpressing ( R )-selective transaminases from Arthrobacter sp. (ArR-ATA and ArRmut-ATA, natural and engineered, respectively) and Aspergillus terreus (AtR-ATA), along with lyophilized amine transaminase (ATAs), were screened for the key asymmetric synthesis of the chiral amine intermediate. Under optimal conditions, conversions above 90% with >99% enantiomeric excess (ee) were achieved. Furthermore, for process intensification purposes, ATA-412 was covalently immobilized onto surface-activated mesoporous methacrylate beads, achieving quantitative immobilization yields. Immobilization and transamination were scaled up 30-fold, and the synthesized chiral amine intermediate was subjected to N-alkylation without isolation, yielding ( R )-tamsulosin hydrochloride. Therefore, after scale-up, this synthesis shows a high potential to replace the current manufacturing process.
No takes yet. Share an insight, caveat, or question.
Lakó et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: